Unilateral vestibular schwannoma with other neurofibromatosis Type 2-related tumors: Clinical and molecular study of a unique phenotype

Journal of Neurosurgery

Volumn 104, Issue 2, 2006, Pages 201-207

  Aghi, Manish ^b   Kluwe, Lan ^b   Webster, Micah T ^b   Jacoby, Lee B ^b   Barker II, Fred G ^b   Ojemann, Robert G ^b   Mautner, Victor Felix ^b   MacCollin, Mia ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Molecular genetics; Mosaicism; Neurofibromatosis Type 2; Tumor suppressor gene; Vestibular schwannoma

Indexed keywords

ADOLESCENT; ADULT; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE LOCUS; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; INTRACRANIAL TUMOR; KAPLAN MEIER METHOD; MALE; MEDICAL RECORD REVIEW; MOLECULAR GENETICS; MOSAICISM; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROIMAGING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PROGENY; REVIEW; SCHOOL CHILD; SPINAL CORD TUMOR; SYMPTOM; VESTIBULAR SCHWANNOMA; VESTIBULOCOCHLEAR NERVE DISEASE;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; FUNCTIONAL LATERALITY; GENES, NEUROFIBROMATOSIS 2; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; PHENOTYPE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33644534169     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.104.2.201     Document Type: Review

References (15)

1. Au KS, Williams AT, Gambello MJ, Northrup H: Molecular genetic basis of tuberous sclerosis complex: from bench to bedside. J Child Neurol 19:699-709, 2004
2. Brackmann DE, Fayad JN, Slattery WH III, Friedman RA, Day JD, Hitselberger WE, et al: Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 49:274-283, 2001
3. Evans DG, Blair V, Strachan T, Lye RH, Ramsden RT: Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females. J Laryngol Otol 109:830-835, 1995
4. Evans DG, Lye R, Neary W, Black G, Strachan T, Wallace A, et al: Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma. J Neurol Neurosurg Psychiatry 66:764-767, 1999
5. Evans DG, Sainio M, Baser ME: Neurofibromatosis type 2. J Med Genet 37:897-904, 2000
6. Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, et al: Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61:1293-1302, 1997
7. Jacoby LB, MacCollin M, Barone R, Ramesh V, Gusella JF: Frequency and distribution of NF2 gene mutations in schwannomas. Genes Chromosomes Cancer 17:45-55, 1996
8. Kluwe L, Mautner V, Heinrich B, Dezube R, Jacoby LB, Friedrich RE, et al: Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas. J Med Genet 40:109-114, 2003
9. Kluwe L, Mautner VF: Mosaicism in sporadic neurofibromatosis 2 patients. Hum Mol Genet 7:2051-2055, 1998
10. Lanser MJ, Sussman SA, Frazer K: Epidemiology, pathogenesis, and genetics of acoustic tumors. Otolaryngol Clin North Am 25:499-520, 1992
11. Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, Haase W, et al: The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38:880-886, 1996
12. Meyers SM, Gutman FA, Kaye LD, Rothner AD: Retinal changes associated with neurofibromatosis 2. Trans Am Ophthalmol Soc 93:245-257, 1995
13. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N: Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-461, 1994
14. Stangerup SE, Tos M, Caye-Thomasen P, Tos T, Klokker M, Thomsen J: Increasing annual incidence of vestibular schwannoma and age at diagnosis. J Laryngol Otol 118:622-627, 2004
15. Viskochil D: Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol 17:562-572, 2002